Robert Gobbo, MD
Family Medicine · Portland, ORNPI 1831125566
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,122 of the $53,035 with a category attached, or 94.5%. Organon accounts for 79.3% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $17,977 and has fallen 59.7% since, to $7,245 in 2025. Among family medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $414.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$42K
- Merck$11K
What the payments were for
- Speaking & faculty fees$50,12295%
- Travel & lodging$1,5143%
- Food & beverage$1,4003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$50,204
How this compares
$53,035 in reported general payments places this provider in the 95th percentile of 1,221 family medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $9,226 |
| Budesonide EcBudesonide | 11 | $6,515 |
| JardianceEmpagliflozin | 22 | $6,247 |
| MyrbetriqMirabegron | 19 | $3,880 |
| FarxigaDapagliflozin Propanediol | 12 | $3,739 |
| Lisinopril | 32 | $720 |
| Duloxetine Hcl | 17 | $471 |
| Levothyroxine Sodium | 34 | $386 |
| Pregabalin | 15 | $351 |
| Atorvastatin Calcium | 17 | $301 |
| Sertraline Hcl | 11 | $249 |
| Carvedilol | 14 | $221 |
| Metformin Hcl | 22 | $212 |
| Amlodipine Besylate | 11 | $194 |
| Donepezil Hcl | 12 | $193 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Portland
- Maureen MaysPortland$24K
- Terena GimmillaroPortland$13K
- Carson BauderPortland$8K
- Alexandra Verdieck DevlaeminckPortland$5K
- Kara KassayPortland$5K
- Whitney RoperPortland$4K
- Eden MillerBend$1.7M
- Anil RajaniHood River$325K
- Stephen NelsonMedford$101K
- Karen KahnAshland$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.